Short sellers looking to profit off “overhyped” Auckland-based antimicrobial product maker Zoono have been blamed for the stock falling 81% since mid-2020.
Shares in the ASX-listed and Auckland-based company hit highs of A$3.2 in July, valuing the company at more than A$500 million before
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
